the obvious reason: their big-spending pharmaceutical advertisers would drop them like hot potatoes.
.
.
now the country may face a fine of millions of euros after its dereliction was referred to the european court of justice (ecj), the guardian reports.
.: "targeted cgrp small molecule antagonists for acute migraine therapy."
.
.